Ancora Advisors, LLC Cytosorbents Corp Transaction History
Ancora Advisors, LLC
- $4.08 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding CTSO
# of Institutions
56Shares Held
15.6MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$2.72 Million0.29% of portfolio
-
Skylands Capital, LLC3MShares$2.64 Million0.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.72 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.48 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.2MShares$1.06 Million0.05% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $38.3M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...